These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 19788607)

  • 1. Adiponectin knockout mice on high fat diet develop fibrosing steatohepatitis.
    Asano T; Watanabe K; Kubota N; Gunji T; Omata M; Kadowaki T; Ohnishi S
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1669-76. PubMed ID: 19788607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin in non-alcoholic steatohepatitis: an ideal culprit, but what are the proofs of its guilt?
    Lanthier N; Leclercq IA
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1584-6. PubMed ID: 19788599
    [No Abstract]   [Full Text] [Related]  

  • 3. Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice.
    Larter CZ; Yeh MM; Van Rooyen DM; Teoh NC; Brooling J; Hou JY; Williams J; Clyne M; Nolan CJ; Farrell GC
    J Gastroenterol Hepatol; 2009 Oct; 24(10):1658-68. PubMed ID: 19788606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.
    Bouter B; Geary N; Langhans W; Asarian L
    Metabolism; 2010 Jul; 59(7):1065-73. PubMed ID: 20045154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoadiponectinemia accelerates hepatic tumor formation in a nonalcoholic steatohepatitis mouse model.
    Kamada Y; Matsumoto H; Tamura S; Fukushima J; Kiso S; Fukui K; Igura T; Maeda N; Kihara S; Funahashi T; Matsuzawa Y; Shimomura I; Hayashi N
    J Hepatol; 2007 Oct; 47(4):556-64. PubMed ID: 17459514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis.
    Lo L; McLennan SV; Williams PF; Bonner J; Chowdhury S; McCaughan GW; Gorrell MD; Yue DK; Twigg SM
    J Hepatol; 2011 Aug; 55(2):435-44. PubMed ID: 21184785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary krill oil supplementation reduces hepatic steatosis, glycemia, and hypercholesterolemia in high-fat-fed mice.
    Tandy S; Chung RW; Wat E; Kamili A; Berge K; Griinari M; Cohn JS
    J Agric Food Chem; 2009 Oct; 57(19):9339-45. PubMed ID: 19761211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.
    Morgan K; Uyuni A; Nandgiri G; Mao L; Castaneda L; Kathirvel E; French SW; Morgan TR
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):843-54. PubMed ID: 18794597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes.
    Larter CZ; Yeh MM; Williams J; Bell-Anderson KS; Farrell GC
    J Hepatol; 2008 Sep; 49(3):407-16. PubMed ID: 18534710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet.
    Baumgardner JN; Shankar K; Hennings L; Badger TM; Ronis MJ
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G27-38. PubMed ID: 17947452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.
    Kubota N; Kado S; Kano M; Masuoka N; Nagata Y; Kobayashi T; Miyazaki K; Ishikawa F
    Clin Exp Pharmacol Physiol; 2013 Jul; 40(7):422-30. PubMed ID: 23611112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telmisartan attenuates progression of steatohepatitis in mice: role of hepatic macrophage infiltration and effects on adipose tissue.
    Kudo H; Yata Y; Takahara T; Kawai K; Nakayama Y; Kanayama M; Oya T; Morita S; Sasahara M; Mann DA; Sugiyama T
    Liver Int; 2009 Aug; 29(7):988-96. PubMed ID: 19386026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice.
    Zheng S; Hoos L; Cook J; Tetzloff G; Davis H; van Heek M; Hwa JJ
    Eur J Pharmacol; 2008 Apr; 584(1):118-24. PubMed ID: 18329014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model.
    Sahai A; Malladi P; Melin-Aldana H; Green RM; Whitington PF
    Am J Physiol Gastrointest Liver Physiol; 2004 Jul; 287(1):G264-73. PubMed ID: 15044174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of murine steatohepatitis models identifies a dietary intervention with robust fibrosis, ductular reaction, and rapid progression to cirrhosis and cancer.
    Wei G; An P; Vaid KA; Nasser I; Huang P; Tan L; Zhao S; Schuppan D; Popov YV
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G174-G188. PubMed ID: 31630534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis.
    Ota T; Takamura T; Kurita S; Matsuzawa N; Kita Y; Uno M; Akahori H; Misu H; Sakurai M; Zen Y; Nakanuma Y; Kaneko S
    Gastroenterology; 2007 Jan; 132(1):282-93. PubMed ID: 17241878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenously synthesized n-3 polyunsaturated fatty acids in fat-1 mice ameliorate high-fat diet-induced non-alcoholic fatty liver disease.
    Kim EH; Bae JS; Hahm KB; Cha JY
    Biochem Pharmacol; 2012 Nov; 84(10):1359-65. PubMed ID: 22981383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis.
    Gäbele E; Dostert K; Dorn C; Patsenker E; Stickel F; Hellerbrand C
    Alcohol Clin Exp Res; 2011 Jul; 35(7):1361-7. PubMed ID: 21463337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis.
    Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM
    Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mouse model for nonalcoholic steatohepatitis.
    Sundaresan S; Vijayagopal P; Mills N; Imrhan V; Prasad C
    J Nutr Biochem; 2011 Oct; 22(10):979-84. PubMed ID: 21190824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.